Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION DIN 02560518

Status: Approved
Holder: BAXTER CORPORATION
Molecule: MICAFUNGIN (MICAFUNGIN SODIUM)
Available to quote

Health Canada record

Active ingredient(s)MICAFUNGIN (MICAFUNGIN SODIUM) 150 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ02AX05 MICAFUNGIN
Original market date
Current status date17-Sep-2025
SourceHealth Canada DPD

Establishment licence of the holder

Baxter Corporation — licence 100278, currently licensed, last inspection rating C (2026-08-11).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MICAFUNGIN (MICAFUNGIN SODIUM)

DINProductCompanyFormStrengthStatus
02543168MICAFUNGIN FOR INJECTIONACCORD HEALTHCARE INCPowder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 50 MGApproved
02543176MICAFUNGIN FOR INJECTIONACCORD HEALTHCARE INCPowder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 100 MGApproved
02560488MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTIONBAXTER CORPORATIONSolutionMICAFUNGIN (MICAFUNGIN SODIUM) 50 MGApproved
02560496MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTIONBAXTER CORPORATIONSolutionMICAFUNGIN (MICAFUNGIN SODIUM) 100 MGApproved
02524961MICAFUNGIN SODIUM FOR INJECTIONJUNO PHARMACEUTICALS CORP.Powder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 100 MGMarketed
02547228MICAFUNGIN SODIUM FOR INJECTIONJUNO PHARMA CANADA INC.Powder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 50 MGMarketed
02547236MICAFUNGIN SODIUM FOR INJECTIONJUNO PHARMA CANADA INC.Powder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 100 MGMarketed
02524953MICAFUNGIN SODIUM FOR INJECTIONJUNO PHARMACEUTICALS CORP.Powder For SolutionMICAFUNGIN (MICAFUNGIN SODIUM) 50 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
360202025-09-17Abbreviated New Drug Submission (ANDS)
Request a quote for MICAFUNGIN IN 0.9% SODIUM CHLORIDE INJECTION

How to read a Canadian DIN record